The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Imprivata sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Smarter leaders trust GlobalData
Imprivata Inc (Imprivata) is an authentication and access management technology solution provider. It offers enterprise access, which is used for authentication. It also provides patient privacy intelligence platform that addresses insider threats. The company offers mobile access management platform which is used for security optimization and management of shared mobile devices. Imprivata offers medical device access management that provides access to medical devices. It also provides patient access, a touchless facial and palm vein recognition providing patient safety. The company operates in the US, the UK, France, Germany, and the Netherlands. Impravata is headquartered in Massachusetts, the US. Key subsidiaries of Imprivata include OGiTiX Software, Fairwarning, SecureLink, HT Systems and Imprivata International.
The key metrics of Imprivata related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:
As Imprivata is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Imprivata.
For a detailed understanding of the performance of Imprivata, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.
